Clare Sheridan

3.5k total citations · 1 hit paper
36 papers, 2.8k citations indexed

About

Clare Sheridan is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Clare Sheridan has authored 36 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Clare Sheridan's work include Cell death mechanisms and regulation (11 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Autophagy in Disease and Therapy (4 papers). Clare Sheridan is often cited by papers focused on Cell death mechanisms and regulation (11 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Autophagy in Disease and Therapy (4 papers). Clare Sheridan collaborates with scholars based in Ireland, United States and United Kingdom. Clare Sheridan's co-authors include Séamus J. Martin, Gabriela Brumatti, Sean P. Cullen, Alexander U. Lüthi, Mohamed Elgendy, J. Walsh, Christopher Gerner, Petrina Delivani, Julian Downward and Ed C. Lavelle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Clare Sheridan

33 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases

2009 564 citations Alexander U. Lüthi, Sean P. Cullen et al. Immunity profile →

Peers

Countries citing papers authored by Clare Sheridan

Since Specialization

Citations

This map shows the geographic impact of Clare Sheridan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Sheridan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Sheridan more than expected).

Fields of papers citing papers by Clare Sheridan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Sheridan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Sheridan. The network helps show where Clare Sheridan may publish in the future.

Co-authorship network of co-authors of Clare Sheridan

This figure shows the co-authorship network connecting the top 25 collaborators of Clare Sheridan. A scholar is included among the top collaborators of Clare Sheridan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare Sheridan. Clare Sheridan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Narrating the psychoneuroimmunomodulatory properties of serotonin 5-HT_2A receptor psychedelics from a transdiagnostic perspective 2025 ·Acta Neuropsychiatrica ·(unknown), Clare Sheridan, (unknown), (unknown), (unknown), (unknown), John R. Kelly, Andrew Harkin	0
2	Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis 2024 ·Cell Reports ·Goran Tomić, Clare Sheridan, (unknown), Marc P. Baggelaar, (unknown), (unknown), Cory A. Ocasio, Alejandro Suárez‐Bonnet, Simon L. Priestnall, Eleanor Herbert, Edward W. Tate, Julian Downward	10
3	Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 kinase in KRAS -Mutant Lung Cancer 2013 ·Cancer Discovery ·Míriam Molina‐Arcas, David C. Hancock, Clare Sheridan, Madhu Kumar, Julian Downward	123
4	Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor Maintenance 2013 ·Cancer Cell ·Esther Castellano, Clare Sheridan, May Zaw Thin, Emma Nye, Bradley Spencer‐Dene, Markus E. Diefenbacher, Christopher Moore, Madhu Kumar, Miguel Murillo, Eva Grönroos, François Lassailly, Gordon Stamp, Julian Downward	139
5	Inhibiting the RAS–PI3K Pathway in Cancer Therapy 2013 ·The Enzymes ·Clare Sheridan, Julian Downward	22
6	Inhibitor of Apoptosis Proteins (IAPs) and Their Antagonists Regulate Spontaneous and Tumor Necrosis Factor (TNF)-induced Proinflammatory Cytokine and Chemokine Production 2012 ·Journal of Biological Chemistry ·Conor J. Kearney, Clare Sheridan, Sean P. Cullen, Graham A. Tynan, Susan E. Logue, Inna S. Afonina, Domagoj Vucic, Ed C. Lavelle, Séamus J. Martin	33
7	Oncogenic Ras-Induced Expression of Noxa and Beclin-1 Promotes Autophagic Cell Death and Limits Clonogenic Survival 2011 ·Molecular Cell ·Mohamed Elgendy, Clare Sheridan, Gabriela Brumatti, Séamus J. Martin	348
8	Value of Cerebral Microhemorrhages Detected with Susceptibility-weighted MR Imaging for Prediction of Long-term Outcome in Children with Nonaccidental Trauma 2010 ·Radiology ·(unknown), Barbara A. Holshouser, Gregory Aaen, Clare Sheridan, Udochukwu Oyoyo, Daniel K. Kido, Stephen Ashwal	64
9	Mitochondrial fission/fusion dynamics and apoptosis 2010 ·Mitochondrion ·Clare Sheridan, Séamus J. Martin	197
10	Bicaudal Is a Conserved Substrate for Drosophila and Mammalian Caspases and Is Essential for Cell Survival 2009 ·PLoS ONE ·Emma M. Creagh, Gabriela Brumatti, Clare Sheridan, Patrick J. Duriez, Rebecca C. Taylor, Sean P. Cullen, Colin Adrain, Séamus J. Martin	11
11	Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases breakdown → 2009 ·Immunity ·Alexander U. Lüthi, Sean P. Cullen, Edel A. McNeela, Patrick J. Duriez, Inna S. Afonina, Clare Sheridan, Gabriela Brumatti, Rebecca C. Taylor, Kristof Kersse, Peter Vandenabeele, Ed C. Lavelle, Séamus J. Martin	564
12	Bax- or Bak-Induced Mitochondrial Fission Can Be Uncoupled from Cytochrome c Release 2008 ·Molecular Cell ·Clare Sheridan, Petrina Delivani, Sean P. Cullen, Séamus J. Martin	215
13	Commitment in apoptosis: slightly dead but mostly alive 2008 ·Trends in Cell Biology ·Clare Sheridan, Séamus J. Martin	12
14	Expression and purification of recombinant annexin V for the detection of membrane alterations on apoptotic cells 2008 ·Methods ·Gabriela Brumatti, Clare Sheridan, Séamus J. Martin	70
15	Predictive value of proton magnetic resonance spectroscopy in pediatric closed head injury 2000 ·Pediatric Neurology ·Stephen Ashwal, Barbara A. Holshouser, Stanford K. Shu, (unknown), Ronald M. Perkin, Lawrence G. Tomasi, David S. Knierim, Clare Sheridan, (unknown), (unknown), David B. Hinshaw	91
16	A video-based performance in noise test for measuring audio-visual disability in young school children: test development, with validation by trained teachers, parents and audiometry as relative standards for disability 1999 ·International Journal of Pediatric Otorhinolaryngology ·Ian Williamson, Clare Sheridan, (unknown), Jørgen Lous	14
17	Comparison of two cochlear implant speech processors in better versus poorer performers. 1995 ·PubMed ·(unknown), (unknown), Fionn Stevenson, Clare Sheridan, N. P. von Haacke	4
18	The development of a test of speech reception disability for use in 5‐ to 8‐year‐old children with otitis media with effusion 1994 ·International Journal of Language & Communication Disorders ·Ian Williamson, Clare Sheridan	6
19	In vivo measurements of bone marrow cellularity using volume‐localized proton NMR spectroscopy 1991 ·Magnetic Resonance in Medicine ·Douglas Ballon, Ann A. Jakubowski, J. Lester Gabrilove, Martin C. Graham, Maureen F. Zakowski, Clare Sheridan, Jason A. Koutcher	56
20	A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer 1991 ·Blood ·John Crown, Ann A. Jakubowski, Nancy E. Kemeny, Michael S. Gordon, Christina Gasparetto, GG Wong, Clare Sheridan, Guy C. Toner, BR Meisenberg, J F Botet	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact